Evidence map›Paper›PMID 27435823›Full record

ArticleMolecular biotechnology2016

Genotyping for Glycophorin GYP(B-A-B) Hybrid Genes Using a Single Nucleotide Polymorphism-Based Algorithm by Matrix-Assisted Laser Desorption/Ionisation, Time-of-Flight Mass Spectrometry.

Ling Wei, Genghis H Lopez, Yanli Ji, Jennifer A Condon, Darryl L Irwin, Guangping Luo, Catherine A Hyland, Robert L Flower

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Universal Detection of MiDiagnostics (Basel, Switzerland) · 2021
    Article
  3. Review
  4. Frequency of MiTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ling WeiClinical Services and Research, Australian Red Cross Blood Service, 44 Musk Avenue, Kelvin Grove, QLD, 4059, Australia.
Genghis H LopezClinical Services and Research, Australian Red Cross Blood Service, 44 Musk Avenue, Kelvin Grove, QLD, 4059, Australia.
Yanli JiInstitute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China.
Jennifer A CondonRed Cell Reference Laboratory, Australian Red Cross Blood Service, 100-154 Batman St., West Melbourne, VIC, 3003, Australia.
Darryl L IrwinAgena Bioscience, Herston, QLD, 4006, Australia.
Guangping LuoInstitute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China.
Catherine A HylandClinical Services and Research, Australian Red Cross Blood Service, 44 Musk Avenue, Kelvin Grove, QLD, 4059, Australia.
Robert L FlowerClinical Services and Research, Australian Red Cross Blood Service, 44 Musk Avenue, Kelvin Grove, QLD, 4059, Australia. rFlower@redcrossblood.org.au.
Australian Red Cross Lifeblood · AUGuangzhou Blood Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic basis for five GP(B-A-B) MNS system hybrid glycophorin blood group antigens results from rearrangement between the homologous GYPA and GYPB genes. Each hybrid glycophorin displays a characteristic profile of antigens. Currently, no commercial serological reagents are currently available to serologically type for these antigens. The aim of this study was to develop a single nucleotide polymorphism (SNP) mapping genotyping technique to allow characterisation of various GYP(B-A-B) hybrid alleles. Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry (MS) assays were designed to genotype five GYP(B-A-B) hybrid alleles. Eight nucleotide positions were targeted and incorporated into the SNP mapping protocol. The allelic frequencies were calculated using peak areas. Sanger sequencing was performed to resolve a GYP*Hop 3' breakpoint. Observed allelic peak area ratios either coincided with the expected ratio or were skewed (above or below) from the expected ratio with switching occurring at and after the expected break point to generate characteristic mass spectral plots for each hybrid. Sequencing showed that the GYP*Hop crossover in the intron 3 region, for this example, was identical to that for GYP*Bun reference sequence. An analytical algorithm using MALDI-TOF MS genotyping platform defined GYPA inserts for five GYP(B-A-B) hybrids. The SNP mapping technique described here demonstrates proof of concept that this technology is viable for genotyping hybrid glycophorins, GYP(A-B-A), GYP(A-B) and GYP(B-A), and addresses the gap in current typing technologies.

Indexed as

Polymorphism, Single NucleotideAlgorithmsGene FrequencyGenotyping TechniquesGlycophorinsHumansSequence Analysis, DNASpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationGlycophorinsGYPA protein, humanGYPB protein, humanGP(B-A-B) hybrid glycophorinGYP(B-A-B) genotypingMALDI-TOF MS genotyping

Identifiers

PMID27435823
OpenAlexW2485725514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.